⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma

Official Title: Phase 1b Study of Carfilzomib Administered Once Weekly in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma

Study ID: NCT02335983

Study Description

Brief Summary: The purpose of the study is to assess the safety, tolerability and activity of a once-weekly regimen of carfilzomib in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Research Site, Bakersfield, California, United States

CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center, Bakersfield, California, United States

Research Site, Burbank, California, United States

Providence Saint Joseph Medical Center, Burbank, California, United States

Research Site, Fountain Valley, California, United States

Compassionate Care Research Group, Inc., Fountain Valley, California, United States

Research Site, Los Angeles, California, United States

Research Site, Los Angeles, California, United States

Los Angeles Hematology / Oncology Medical Group, Los Angeles, California, United States

Research Site, Whittier, California, United States

Research Site, Aurora, Colorado, United States

University of Colorado, Aurora, Colorado, United States

Research Site, Washington, District of Columbia, United States

Lombardi Cancer Center, Pediatric Hematology Oncology, Washington, District of Columbia, United States

Research Site, Fort Myers, Florida, United States

Florida Cancer Specialists, Fort Myers, Florida, United States

Research Site, Tampa, Florida, United States

H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

Research Site, West Palm Beach, Florida, United States

Florida Cancer Specialists, West Palm Beach, Florida, United States

University of Chicago Medical Center, Chicago, Illinois, United States

Research Site, Boston, Massachusetts, United States

Dana Farber Partners Cancer Care, Boston, Massachusetts, United States

Research Site, Ann Arbor, Michigan, United States

Research Site, Hackensack, New Jersey, United States

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

Research Site, New York, New York, United States

Research Site, New York, New York, United States

Clinical Research Alliance, New York, New York, United States

Memorial Sloan Kettering, New York, New York, United States

Morton Coleman, MD, New York, New York, United States

Weill Cornell Medical College, New York, New York, United States

Research Site, Stony Brook, New York, United States

Stony Brook University Medical Center, Stony Brook, New York, United States

Research Site, Durham, North Carolina, United States

Durham Veterans Affairs Medical Center, Durham, North Carolina, United States

Research Site, Cincinnati, Ohio, United States

Sarah Cannon Research Institute, Cincinnati, Ohio, United States

Research Site, Bend, Oregon, United States

Bend Memorial Clinic, Bend, Oregon, United States

Research Site, Charleston, South Carolina, United States

Medical University of South Carolina, Hollings Cancer Center, Charleston, South Carolina, United States

Research Site, Greenville, South Carolina, United States

Greenville Health System, Greenville, South Carolina, United States

Saint Francis Hospital Cancer Center, Greenville, South Carolina, United States

Research Site, Sioux Falls, South Dakota, United States

Avera Cancer Institute, Sioux Falls, South Dakota, United States

Research Site, Germantown, Tennessee, United States

The West Clinic, PC, Memphis, Tennessee, United States

Research Site, Nashville, Tennessee, United States

Research Site, Nashville, Tennessee, United States

Tennessee Oncology, PLLC / The Sarah Cannon Research lnstitute, Nashville, Tennessee, United States

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Research Site, Salt Lake City, Utah, United States

Huntsman Cancer Institute, Salt Lake City, Utah, United States

Research Site, Seattle, Washington, United States

Swedish Cancer Institute, Seattle, Washington, United States

Aurora Health Care, Aurora Cancer Care, Milwaukee, Wisconsin, United States

Research Site, Wauwatosa, Wisconsin, United States

Contact Details

Name: Amy Kimball, MD

Affiliation: Amgen

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: